Abstract
Zinc is an important trace element for structure, and regulation in the central nervous system, as well as the gut homeostasis. There are several mental disorders associated with zinc deficiency. The relationship between zinc nutritional status with mood states and quality of life (QoL) in diarrhea-predominant irritable bowel syndrome (IBS-D) has not been studied yet. This case–control study aimed to investigate the association between zinc nutritional status with mood states and QoL in IBS-D patients. Sixty-one newly diagnosed patients with IBS-D and 61 matched healthy controls were enrolled. Dietary zinc intakes and serum zinc levels were measured. Mood states and QoL were evaluated by validated questionnaires. Logistic regression was used to estimate the odds of IBS-D in relation to zinc deficiency. Decreased serum zinc levels were observed in the IBS-D group than in the controls (p = 0.001). There were higher scores of depression (p = 0.014), anxiety (p = 0.005), and stress (p = 0.001) among IBS-D patients. Moreover, overall QoL, physical and psychological health were lower in IBS-D patients compared to the controls (p < 0.001). “Food avoidance” had the lowest, while the “relationship” had the highest score among the patients (51.09 ± 26.80 and 78.14 ± 23.30, respectively). Dietary zinc intake was positively correlated with psychological health in the controls (r = 0.295, p = 0.022) and with body image in the patients (r = 0.266, p = 0.044). According to the logistic regression, zinc deficiency was not significantly associated with odds of IBS-D. Findings show that zinc deficiency may be associated with some parameters of IBS-D. Further clinical studies are needed to explore the causal relationship between zinc status and IBS pathogenesis.
Similar content being viewed by others
Introduction
Irritable bowel syndrome (IBS) is a functional gastrointestinal (GI) disorder with abdominal pain and alterations in stool frequency or form1. It can affect anyone, regardless of age, sex, or race2. Nevertheless, IBS is more common among people with psychological disorders and young adult women than among those in the general population3. Based on a previous meta-analysis, global estimation of the IBS prevalence is 11%4. Anxiety, depression, life events and stress, frequent healthcare use, and sleep disorders are the most common risk factors for IBS5. IBS is accompanied by depression or anxiety in 40–60% of cases, and these patients have a high frequency of somatic symptoms. Mood disorders, the severity of GI symptoms, and somatization are contributed to the reduced quality of life (QoL) in IBS patients6. Although IBS is not related to higher mortality rates, considering medical costs and reduced health-related QoL, it imposes significant burden on patients and society7. A healthy diet and appropriate nutrition not only contribute to physical health but also mental well-being and mood stability8.
Zinc is one of the most important nutrients which has significant importance for public health. It plays a critical role in biochemical pathways, such as response to oxidative stress, homeostasis, and immunological responses9. Almost 17.3% of people in the world suffer from zinc deficiency, which affects many organs10. Zinc is essential for neuronal impulses, and its deficiency impacts on mental wellbeing, brain growth, and behavior. The alteration of brain zinc levels has been implicated in a wide range of diseases such as Alzheimer's disease, Parkinson's disease, and mood disorders including depression11,12. A study showed subjects with anxiety had significantly higher plasma copper and lower zinc levels in comparison to their controls13. Moreover, a recent study found that serum zinc concentration is a useful marker of reduced health-related QoL in patients with chronic liver diseases14. Previous studies have indicated that there is a lower intake or serum zinc levels in patients with IBS but they did not examine its relation with mood and QoL15,16,17. Therefore, this case–control study purposed to evaluate the correlation between zinc nutritional status with mood states and QoL and the association of zinc deficiency with odds of IBS-D in diarrhea-predominant patients with irritable bowel syndrome (IBS-D).
Subjects and methods
Participants
The present case–control study was conducted on 61 IBS-D patients and 61 healthy matched controls, from April 2020 to January 2021, at Isfahan University of Medical Sciences Khorshid and Al-Zahra Hospital clinics. Based on Rome IV criteria, a gastroenterologist diagnosed new cases of IBS-D patients18. Study participants were men and women aged 20–55 with a body mass index (BMI) below 30 kg/m2. The exclusion criteria were: any evidence of abdominal surgery, celiac or other primary GI diseases and infection, pregnancy, lactation, malignancy, routine consumption of artificial sweeteners19, smoking and alcohol drinking habit, chronic anemia, concurrent chronic diseases, taking medications including glucocorticoids, non-steroidal anti-inflammatory drugs, antibiotics, antidiarrheal and antipsychotic drugs, having special diet or taking dietary supplements such as zinc during the last six months as well as being a professional athlete. Individuals without IBS (according to the gastroenterologist diagnosis) were selected among friends of the patients and were considered as the healthy controls. The frequency matching method was used to match the cases and controls based on their age and sex. The study was conducted according to the declaration of Helsinki and the STROBE checklist. All participants provided written informed consent and the study protocol was approved by the Medical Ethics Committee at the Isfahan University of Medical Sciences (reg. no. IR.MUI.RESEARCH.REC.1398.826).
Demographic and anthropometric assessment
A general questionnaire was used to assess the educational level, employment, age, and drug history. Height was measured at a standing position without shoes using a fixed non-stretchable tape at 0.1 cm precision. Omron BF511 set was used to measure weight in minimal clothing. Waist circumference at the midpoint between the iliac crest and the last rib was assessed. The hip circumference was measured around the widest part of the buttocks. Body mass index was computed as dividing weight (kg) by height (m2).
Dietary assessment
Dietary intake of all participants were gathered using a 3-day dietary record (two working days and one weekend day)20. We converted the portion sizes of foods consumed into grams. Customized Nutritionist IV software (First Databank Inc., Hearst Corp., San Bruno, CA, USA) was used for dietary analysis based on Iranian foods.
Biochemical assessment
After 10–12 h of fasting, blood samples were collected from the cubital vein in all participants. Serums were separated, then were stored at − 80 °C until further assays. Serum zinc levels were measured using the colorimetric method (Zinc assay kit, Kiazist, Hamedan, Iran). The accuracy of this kit is close to the results obtained by atomic absorption spectrophotometry method21. We considered serum zinc levels less than 70 µg/dL as zinc deficiency22.
Mood states
Participants were evaluated for depression, anxiety and stress scores using a 21-item questionnaire (DASS-21). Validation of this questionnaire was investigated previously among the Iranian population23. There were four response options, ranging from 0 (did not apply to me at all) to 3 (applied to me most of the time). Afterward, based on the scores in each question, each parameter of depression, anxiety, and stress was calculated.
Quality of life
We used two questionnaires to assess the QoL. A self-report 34-item IBSQoL questionnaire was provided to IBS patients24. The Persian version of this instrument is reliable and validated having high internal consistency (Cronbach’s alpha, 0.94)25. IBSQoL questionnaire has 8 subscales including "dysphoria", "interference with activity", "body image", "health worry", "food avoidance", "social reaction", "sexual worries" and "relationship". A five-point response scale from 1 (always) to 5 (never) was used to measure sufferers’ QoL. Scores of all items and items for each subscale were summed to calculate total scores and were converted to scales between 0 to 100. Higher scores indicated better QoL.
World Health Organization QoL questionnaire (WHOQOL)-BREF, 26 items, was used to comparison QoL between 2 groups. It has acceptable validity and reliability in its Persian version26. Questions 1 and 2 are used to measure the overall QoL and general health, and other 24 items evaluate 4 domains such as social relationships, psychological, environmental, and physical health. The items are given a 5-point Likert scale, and each domain is determined by summing its specific items. Also, a higher score showed higher QoL.
Statistical analysis
We used SPSS software version 24 (SPSS Inc., Chicago, IL, USA) to perform statistical analyses. In order to show the normal distribution of variables, Kolmogrov-Smirnov test was applied. Independent t test was performed to compare quantitative variables means and Chi-square test was used to compare qualitative variables between the groups. Linear correlations between continuous quantitative variables were applied using Pearson's test. To estimate the association between serum zinc levels and odds of IBS-D, logistic regression was conducted. In the adjusted model, employment, educational level, dietary zinc intake, depression, anxiety, stress, overall QoL and general health, physical health, and psychological health were controlled. Statistical significance was defined at p-value < 0.05.
Ethical approval and consent to participate
The present study was extracted from the MSc dissertation of MR that has been approved by the Vice-Chancellor for research, Isfahan University of Medical Sciences (reg. code IR.MUI.RESEARCH.REC.1398.826).
Results
General characteristics of participants in the two groups are described in Table 1. The employment and educational levels were significantly different between the cases and controls (p = 0.031 and 0.043, respectively). The significant differences were not observed between IBS-D patients and healthy controls in terms of age, gender, anthropometric measurements, dietary intakes of zinc, as well as other nutrients intakes. The serum zinc levels were lower in IBS-D patients than those in healthy controls (p = 0.001). Although the number of subjects with zinc deficiency was higher in IBS-D patients, it was not different between the two groups.
Table 2 demonstrates the higher scores of depression (p = 0.014), anxiety (p = 0.005), as well as stress (p = 0.001), and lower overall QoL and general health, physical health, and psychological health scores (p ≤ 0.001) among IBS-D patients compared to the healthy ones. According to the IBS-QoL questionnaire, “food avoidance” had the lowest (51.09 ± 26.80), and “relationship” had the highest score (78.14 ± 23.30) in IBS-D patients.
Dietary zinc intakes and components of mood states in the two groups showed no correlation (Table 3). Dietary zinc intakes were directly correlated with psychological health scores in the controls (r = 0.295, p = 0.022) and with body image in the IBS-D group (r = 0.266, p = 0.044). Also, there was a marginal positive correlation between dietary zinc intakes and physical health score in healthy controls (r = 0.245, p = 0.06).
Correlation between serum zinc levels with mood states and QoL is presented in Table 4. Although a significant correlation was not found, a marginally positive correlation between levels of serum zinc and social reaction, as one of the components of IBS-QoL, was observed in the IBS-D group (r = 0.241, p = 0.061).
The Logistic regression showed no significant association between zinc deficiency and odds of IBS-D in both crude and adjusted models (OR: 1.775; 95% CI: 0.840–3.751; OR: 2.41; 95% CI: 0.849–6.840, respectively) (Table 5).
Discussion
In the previous study, we evaluated the correlation between zinc nutritional status with serum zonulin, as a serum marker of intestinal permeability, and gastrointestinal symptoms in IBS-D patients27. The findings of the present study revealed that the serum concentration of zinc was lower in patients compared to their controls. The intestine is the main route of absorption and excretion of zinc. Decreased absorption, as well as increased fecal excretion of zinc, and gut dysbiosis might be considered as potential causes of low levels of serum zinc in IBS patients. Gut dysbiosis can alter the functional capacity of the microflora, resulting in decreased mineral absorption, carbohydrate digestion and fermentation, and short-chain fatty acid production. These effects may reduce zinc bioavailability and disturb GI and mental health28,29,30. Current investigation showed that the mood states and QoL were impaired in IBS-D patients. Although, a significant positive correlation was observed between dietary zinc intakes and psychological health in the control group, the other components of the QoL were not correlated with dietary intakes of zinc in both groups. Moreover, IBS-QoL, showed that body image was positively correlated with dietary intakes of zinc. The aforementioned reasons may be involved in this correlation. However, there was no significant correlation between serum zinc and components of mood states and QoL.
In agreement with our findings, a preliminary study by Cavallo et al. reported low serum zinc levels and increased fecal excretion of zinc in two subgroups of IBS patients15. In contrast, other studies on patients with IBS showed no significant differences in serum levels of zinc between the cases and controls31,32. Although our finding indicated no differences in dietary zinc intakes between the groups, some studies reported that dietary intake of zinc in IBS patients was lower than those of healthy subjects16,17.
Irritable bowel syndrome is not a life-threatening disease, however, it can affect the normal life of patients. Our findings illustrated that the lower QoL and higher severity of depression, anxiety, and stress are related to IBS-D. Some studies suggested that the QoL score was significantly lower in IBS patients compared to their healthy subjects33,34. Physical discomfort, food avoidance, sexual problems, psychological disease, sleep disorders, fatigue, and functional disorders can contribute to the declined QoL of these patients35. A meta-analysis by Zhang et al. showed that symptoms of depression were greater in IBS patients in comparison to the healthy ones36. In agreement with our findings, two studies that assessed mood status by DASS questionnaire observed that the scores of stress, anxiety and depression were higher in IBS patients37,38. Alteration in intestinal microbiota and abnormal function of the gut-brain axis are possible mechanisms for mood alterations in IBS39,40.
According to our results, there was a direct correlation between dietary zinc intake and psychological health in the control group and body image in the IBS-D group. In contrast to our findings, previous studies found a significant association between zinc nutritional status with mood and QoL. A case–control study in Iran conducted on the major depressive disorder (MDD) female students reported a linear inverse correlation between dietary and serum zinc levels and Beck’s scores41. In addition, review by Elise et al. demonstrated that zinc deficiency was associated with mood disorders and supplementation with zinc might have beneficial role in the treatment of these disorders42. Regarding the QoL and zinc status, a double-blind randomized and placebo-controlled trial reported that supplementation with zinc sulfate had a beneficial effect on improving the health-related QoL and its components in women with premenstrual syndrome43. However, a cross-sectional study conducted on 297 elderly subjects indicated no significant association between dietary or serum zinc and anxiety. Noteworthy, low serum zinc levels, but not dietary zinc, were associated with higher odds of depression44. Differences in dietary assessment tools, sample size, and health status of the participants might be regarded as the sources of inconsistency in studies results.
As the possible underlying mechanisms, higher receptors of serotonin in the hippocampus and frontal cortex, modulation of glutamate signaling, elevated concentration of brain-derived neurotrophic factor (BDNF) in the hippocampus and cortex, and antioxidant activity of zinc are proposed for the antipsychotic effects of this trace element45,46. Therefore, impaired zinc homeostasis can lead to states of cognitive, emotional, and behavioral problems.
The result of our study indicated that the association between zinc deficiency and odds of IBS-D might be confounded by variables such as employment and educational status, dietary zinc intake, components of QoL, and general health status. Therefore, with adjustment for these confounding variables, the association of zinc deficiency with IBS-D odds became stronger compared to the crude model.
This study had some strengths. To the best of our knowledge, this is the first study that has investigated the correlation of zinc nutritional status with mood disorders and QoL in IBS-D patients. In addition, to prevent alteration in common dietary intakes and food habits, newly diagnosed IBS-D patients were considered as the cases group.
As a limitation, we did not use a semi-quantitative FFQ to assess the usual dietary intakes during the last year. Also, we were unable to measure other biomarkers such as serum metallothionein concentrations.
Conclusion
In the present study, serum zinc levels, overall QoL, physical and psychological health were lower and scores of depression, anxiety, and stress were higher in IBS-D patients. In addition, higher dietary intake of zinc correlated with improvements in psychological health and body image in the controls and cases, respectively. Further research with prospective and clinical trial design is warranted to illustrate any causal relationship.
Data availability
The datasets generated and/or analysed during the current study are not publicly available as per the rules and regulations of the Department of Clinical Nutrition at the Isfahan University of Medical Science but are available upon reasonable request from the corresponding author.
References
Cash, B. & Chey, W. Irritable bowel syndrome—an evidence-based approach to diagnosis. Aliment. Pharmacol. Ther. 19, 1235–1245 (2004).
Ferreira, A. I., Garrido, M. & Castro-Poças, F. Irritable bowel syndrome: News from an old disorder. GE-Portuguese J. Gastroenterol. 27, 255–268 (2020).
Black, C. J., Yiannakou, Y., Houghton, L. A. & Ford, A. C. Epidemiological, clinical, and psychological characteristics of individuals with self-reported irritable bowel syndrome based on the Rome IV vs Rome III criteria. Clin. Gastroenterol. Hepatol. 18, 392-398.e392 (2020).
Lovell, R. M. & Ford, A. C. Global prevalence of and risk factors for irritable bowel syndrome: A meta-analysis. Clin. Gastroenterol. Hepatol. 10, 712-721.e714 (2012).
Creed, F. the incidence and risk factors for irritable bowel syndrome in population-based studies. Aliment. Pharmacol. Ther. 50, 507–516 (2019).
Liang, A. M. & Tien, Y. Quality of life in irritable bowel syndrome: A narrative overview. J. Arch. Military Med. 4, e36624 (2016).
Weaver, K. R., Melkus, G. D. E. & Henderson, W. A. Irritable bowel syndrome. Am. J. Nurs. 117, 48–55 (2017).
Muscaritoli, M. The impact of nutrients on mental health and well-being: Insights from the literature. Front. Nutr. 8, 97 (2021).
Chasapis, C. T., Ntoupa, P.-S.A., Spiliopoulou, C. A. & Stefanidou, M. E. Recent aspects of the effects of zinc on human health. Arch. Toxicol. 94, 1443–1460 (2020).
Wessells, K. R. & Brown, K. H. Estimating the global prevalence of zinc deficiency: Results based on zinc availability in national food supplies and the prevalence of stunting. PLoS ONE 7, e50568 (2012).
Butola, L. K., Ambad, R. & Kacchwa, K. Zinc and psychiatric disorders: A review. Int. J. Res. Pharma. Sci. 11, 1505–1514 (2020).
Du, K., Liu, M.-Y., Zhong, X. & Wei, M.-J. Decreased circulating Zinc levels in Parkinson’s disease: A meta-analysis study. Sci. Rep. 7, 1–8 (2017).
Russo, A. Decreased zinc and increased copper in individuals with anxiety. Nutr. Metab. Insights 4, NMI.S6349 (2011).
Nishikawa, H. et al. Serum zinc concentration and quality of life in chronic liver diseases. Medicine 99, e18632 (2020).
Cavallo, G., De Magistris, R., Miluccio, V. & Iannuzzi, R. Changes in the blood zinc in the irritable bowel syndrome: A preliminary study. Minerva Dietol. Gastroenterol. 36, 77–81 (1990).
Bahrami, A. et al. The association of trace elements with premenstrual syndrome, dysmenorrhea and irritable bowel syndrome in adolescents. Eur. J. Obstetr. Gynecol. Reproduct. Biol. 233, 114–119 (2019).
Torres, M. J. et al. Food consumption and dietary intakes in 36,448 adults and their association with irritable bowel syndrome: Nutrinet-Sante study. Therap. Adv. Gastroenterol. 11, 1756283X17746625 (2018).
Defrees, D. N. & Bailey, J. Irritable bowel syndrome: Epidemiology, pathophysiology, diagnosis, and treatment. Primary Care: Clin. Office Pract. 44, 655–671 (2017).
Shil, A. et al. Artificial sweeteners disrupt tight junctions and barrier function in the intestinal epithelium through activation of the sweet taste receptor, T1R3. Nutrients 12, 1862 (2020).
Yang, Y. J. et al. Relative validities of 3-day food records and the food frequency questionnaire. Nurs. Res. Pract. 4, 142–148 (2010).
Song, M., Adham, N. & Rinderknecht, H. A simple, highly sensitive colorimetric method for the determination of zinc in serum. Am. J. Clin. Pathol. 65, 229–233 (1976).
Hotz, C. & Brown, K. H. Assessment of the risk of zinc deficiency in populations and options for its control. (2004).
Sahebi, A., Asghari, M. J. & Salari, R. S. Validation of depression anxiety and stress scale (DASS-21) for an Iranian population. J. Iran. Psychol. 4, 299–313 (2005).
Drossman, D. A. et al. Further validation of the IBS-QOL: A disease-specific quality-of-life questionnaire. Am. J. Gastroenterol. 95, 999–1007 (2000).
Gholamrezaei, A. et al. Linguistic validation of the irritable bowel syndrome-quality of life questionnaire for Iranian patients. Acta Med. Iran. 49, 390–395 (2011).
Usefy, A. et al. Psychometric properties of the WHOQOL-BREF in an Iranian adult sample. Community Ment. Health J. 46, 139–147 (2010).
Rezazadegan, M., Soheilipour, M., Tarrahi, M. J. & Amani, R. Correlation between zinc nutritional status with serum zonulin and gastrointestinal symptoms in diarrhea-predominant irritable bowel syndrome: A case-control study. Dig. Dis. Sci. 6, 1–7 (2022).
Koren, O. & Tako, E. Chronic dietary zinc deficiency alters gut microbiota composition and function. Proceedings 61, 16 (2020).
Semrad, C. E. Zinc and intestinal function. Curr. Gastroenterol. Rep. 1, 398–403 (1999).
Mörkl, S. et al. The role of nutrition and the gut-brain axis in psychiatry: A review of the literature. Neuropsychobiology 79, 80–88 (2020).
Jin, H. et al. T lymphocyte subgroups and serum levels of trace elements in patients with diarrhea type of irritable bowel syndrome. J. Zhejiang Univ. Med. Sci. 37, 634–637 (2008).
Hujoel, I. A. Nutritional status in irritable bowel syndrome: A North American population-based study. JGH Open 4, 656–662 (2020).
Jamali, R. et al. Health related quality of life in irritable bowel syndrome patients, Kashan, Iran: A case control study. Adv. Biomed. Res. 4, 75 (2015).
Jang, S.-H., Ryu, H.-S., Choi, S.-C. & Lee, S.-Y. Psychological factors influence the irritable bowel syndrome and their effect on quality of life among firefighters in South Korea. Psychiatry Investig. 14, 434 (2017).
Enck, P. et al. Irritable bowel syndrome. Nat. Rev. Dis. Primers. 2, 16014 (2016).
Zhang, Q.-E. et al. Depressive symptoms in patients with irritable bowel syndrome: A meta-analysis of comparative studies. Int. J. Biol. Sci. 14, 1504 (2018).
Erfan, A., Noorbala, A., Afshar, H. & Adibi, P. Emotional schemas of patients with irritable bowel syndrome and their relationship to psychological symptoms. Int. J. Body Mind Cult. 4, 36–45 (2017).
Dibajnia, P., Moghadasin, M., Madahi, M. E. & Keikhayfarzaneh, M. M. Depression, anxiety, stress, anger in IBS patients. J. Pure Appl. Microbiol. 7, 175–180 (2013).
Mayer, E. A., Savidge, T. & Shulman, R. J. Brain–gut microbiome interactions and functional bowel disorders. Gastroenterology 146, 1500–1512 (2014).
Fukudo, S. & Kanazawa, M. Gene, environment, and brain-gut interactions in irritable bowel syndrome. J. Gastroenterol. Hepatol. 26, 110–115 (2011).
Amani, R., Saeidi, S., Nazari, Z. & Nematpour, S. Correlation between dietary zinc intakes and its serum levels with depression scales in young female students. Biol. Trace Elem. Res. 137, 150–158 (2010).
Cope, E. C. & Levenson, C. W. Role of zinc in the development and treatment of mood disorders. Curr. Opin. Clin. Nutr. Metab. Care 13, 685–689 (2010).
Jafari, F., Tarrahi, M. J., Farhang, A. & Amani, R. Effect of zinc supplementation on quality of life and sleep quality in young women with premenstrual syndrome: A randomized, double-blind, placebo-controlled trial. Arch. Gynecol. Obstet. 302, 657–664 (2020).
Anbari-Nogyni, Z. et al. Relationship of zinc status with depression and anxiety among elderly population. Clin. Nutr. ESPEN 37, 233–239 (2020).
Cichy, A. et al. Zinc-induced adaptive changes in NMDA/glutamatergic and serotonergic receptors. Pharmacol. Rep. 61, 1184–1191 (2009).
Wang, J., Um, P., Dickerman, B. A. & Liu, J. Zinc, magnesium, selenium and depression: A review of the evidence, potential mechanisms and implications. Nutrients 10, 584 (2018).
Acknowledgements
We thank all participants for their good cooperation in this study.
Funding
This study was financially supported by the grant from Vice-Chancellor for Research of Isfahan University of Medical Sciences.
Author information
Authors and Affiliations
Contributions
M.R. participated in designing, data collection, and interpretation of analyzed outputs. F.S.H. wrote the first draft. M.S. was a gastroenterologist and managed the patients. M.J.T. performed the statistical analysis. R.A. designed and supervised the study and edited the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Rezazadegan, M., Shahdadian, F., Soheilipour, M. et al. Zinc nutritional status, mood states and quality of life in diarrhea-predominant irritable bowel syndrome: a case–control study. Sci Rep 12, 11002 (2022). https://doi.org/10.1038/s41598-022-15080-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-022-15080-2
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.